RGEN
USDRepligen Corporation Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$149.060
고가
$151.250
저가
$146.000
거래량
0.61M
기업 기본 정보
시가총액
8.3B
산업
Medical Instruments & Supplies
국가
United States
거래 통계
평균 거래량
0.92M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Repligen Corporation to Present at Upcoming November Conferences
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165
Canaccord Genuity analyst Kyle Mikson maintains Repligen with a Hold and raises the price target from $150 to $165.
Barclays Maintains Overweight on Repligen, Raises Price Target to $175
Barclays analyst Luke Sergott maintains Repligen with a Overweight and raises the price target from $160 to $175.
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchisesOrders increased sequentially and greater than 20% year-over-yearIncreasing
Repligen to Report Third Quarter 2025 Financial Results
WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will
